Related Experiment Video
Updated: Jul 28, 2026
13:19
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
Prostate cancer: simplicity to complexity.
1Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA.
Nature Genetics
|February 15, 2001
Summary
Two new studies reveal key factors in prostate cancer development. Researchers identified a new candidate gene, ELAC2, and demonstrated how Cdkn1b and Pten genes work together to suppress prostate tumors.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Prostate cancer arises from complex genetic and environmental interactions.
- Understanding the molecular mechanisms of prostate cancer is crucial for developing effective treatments.
Purpose of the Study:
- To identify novel candidate genes involved in prostate cancer.
- To elucidate the cooperative roles of specific genes in tumor suppression.
Main Methods:
- Gene mapping and cloning of the ELAC2 candidate gene.
- Functional analysis of the cooperative interaction between Cdkn1b and Pten in prostate tumor suppression.
Main Results:
- Identification and characterization of the ELAC2 gene as a potential contributor to prostate cancer.
- Demonstration of a synergistic tumor-suppressive effect of Cdkn1b and Pten.
Conclusions:
- The ELAC2 gene represents a new target for prostate cancer research.
- Coordinated action of Cdkn1b and Pten is vital for maintaining prostate health and preventing tumor formation.
Related Concept Videos
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:20Disorders of the Male Reproductive System
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...